| Name: | Anagrelide Related Compound A |
| Catalogue No. | VL2810001 |
| CAS No. | 85325-12-8 |
| Molecular Formula | C11H14N2Cl2O2·HCl |
| Molecular Weight | 313.61 |
| Status | In-stock |
| IUPAC Name | N-[(6-amino-2,3-dichlorophenyl)methyl]glycine Ethyl Ester Hydrochloride |
| Description | Anagrelide Related Compound A(CAS No: 85325-12-8) or N-[(6-amino-2,3-dichlorophenyl)methyl]glycine Ethyl Ester Hydrochloride, used to treatment of secondary to malignant neoplasms by inhibiting phosphodiesterase 3A |
| References | Birgegård, Gunnar. “The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia.” Current Hematologic Malignancy Reports, vol. 11, no. 5, 6 Aug. 2016, pp. 348–355, www.ncbi.nlm.nih.gov/pmc/articles/PMC5031713/, 10.1007/s11899-016-0335-0. |
